MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

TransMedics touts first U.S. ‘reanimated’ heart transplants

December 4, 2019 By Nancy Crotti Leave a Comment

TransMedics (NSDQ:TMDX) announced today that the doctors at two hospitals performed the first U.S. heart transplants using donor hearts that were resuscitated using the company’s organ care system (OCS). The transplants from donation after circulatory death (DCD) took place at Duke University Hospital in Durham, N.C. and Massachusetts General Hospital in Boston. In a DCD procedure, […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Transplants, Wall Street Beat Tagged With: Duke University, Massachusetts General Hospital, transmedics

FDA: Abiomed Impella RP survival rate steady when appropriate patients are implanted

December 3, 2019 By Nancy Crotti Leave a Comment

The survival rate of right-heart failure patients treated with the Abiomed (NSDQ:ABMD) Impella RP heart pump remained about the same during the latest round of post-approval studies, according to the FDA. That latest rate of survival 30 days post-explant, post-discharge survival or switch to another therapy rate was 72.7%, or 16 out of 22 patients among […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Abiomed, FDA

Ra Medical shares begin recovery following report of Q3 losses, material weakness

December 2, 2019 By Nancy Crotti Leave a Comment

Ra Medical Systems (NYSE:RMED) reported third-quarter losses of $17.4 million last week amidst an internal investigation into failures surrounding its Dabra laser catheters and other shortcomings. That investigation, announced in August, recently revealed deficiencies in its internal controls that constitute a material weakness and could have resulted in material misstatements or omissions to its financial statements […]

Filed Under: Business/Financial News, Catheters, Featured, Wall Street Beat Tagged With: Ra Medical, Securities & Exchange Commission (SEC)

Baxter spending $350m to acquire surgical adhesion barrier tech from Sanofi

December 2, 2019 By Chris Newmarker Leave a Comment

Baxter (NYSE:BAX) said today that it will buy the Seprafilm adhesion barrier and related assets from Sanofi (NYSE:SNY) in what is expected to be a $350 million deal. The purchase is expected to close no later than the first quarter of 2020. A Bloomberg report in October hinted that a deal might be in the work. “While […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat, Wound Care Tagged With: Baxter, Sanofi

Appeals court tosses former Abiomed Asia exec’s lawsuit

December 2, 2019 By Nancy Crotti Leave a Comment

This article has been updated with a comment from Abiomed. A federal appeals court has dismissed the wrongful termination law suit of a former Asia VP for Abiomed (NSDQ:ABMD). The three-judge panel ruled on Nov. 27  that Keisuke Suzuki failed to prove that Abiomed owed him compensation in the form of company stock options for […]

Filed Under: Cardiovascular, Featured, Legal News, Wall Street Beat Tagged With: Abiomed

Baxter gets filing deadline from stock exchange

November 25, 2019 By Nancy Crotti Leave a Comment

The New York Stock Exchange notified Baxter (NYSE:BAX) on Friday that the company has until May 20, 2020 to file its third-quarter financial report and any subsequent delayed filings to regain compliance with exchange’s listing standards. The Deerfield, Ill.–based healthcare products company announced Nov. 15 that it was conducting an internal probe into its foreign […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: Baxter

Axonics places $110 million public offering

November 21, 2019 By Sean Whooley Leave a Comment

Sacral neuromodulation device-maker Axonics Modulation Technologies (NSDQ:AXNX) has commenced a proposed public offering worth more than $100 million in shares of its common stock. The offering is placed at $110 million, with Irvine, Calif.-based Axonics expecting to offer $100 million in shares to go along with $10 million in shares offered by selling stockholders. Axonics plans […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Axonics Modulation Technologies, FDA, Medtronic

Carlisle completes Providien purchase

November 20, 2019 By Sean Whooley Leave a Comment

Carlisle Companies (NYSE:CSL) announced today that it has completed its acquisition of Providien for an undisclosed amount. San Diego-based Providien provides solutions for global medical technology OEMs, such as contract manufacturing, precision machining and metals, thermoforming and injection molding. The acquisition, which was initially announced last month, is part of Scottsdale, Ariz.-based Carlisle’s plan to […]

Filed Under: Contract Manufacturing, Mergers & Acquisitions, Wall Street Beat Tagged With: Carlisle Companies, Providien

Stent makers point to quality-of-life findings by massive federal study

November 20, 2019 By Nancy Crotti Leave a Comment

The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]

Filed Under: Business/Financial News, Cardiovascular, Clinical Trials, Drug-Eluting Stents, Featured, Stents, Vascular, Wall Street Beat Tagged With: Abbott, American Heart Association, B. Braun, Boston Scientific, Cardinal Health, Medtronic, MicroPort Scientific, Society for Cardiovascular Angiography & Intervention, Terumo

Abiomed stock recovers some as company further questions critical Impella studies

November 19, 2019 By Chris Newmarker Leave a Comment

Shares of heart pump company Abiomed (NSDQ:ABMD) recovered a bit today — a day after the company’s stock took a 20% dive after two critical studies came out of American Heart Association’s Scientific Sessions. The two separate studies — one led by researchers in St. Louis, the other out of San Francisco — suggested potentially serious complications […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Wall Street Beat Tagged With: Abiomed

Getinge shares drop on news of more deaths, injuries linked to faulty IABPs

November 19, 2019 By Nancy Crotti Leave a Comment

Shares of Getinge (STO:GETI-B) dropped 5% today on news that the FDA had received 60 more reports of adverse events — including two deaths and one serious injury — related to the company’s Maquet/Datascope intraortic balloon pumps (IABP). The FDA said the new reports have come in since it issued a letter in November 2018 […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Recalls, Regulatory/Compliance, Wall Street Beat Tagged With: FDA, Getinge

  • 1
  • 2
  • 3
  • …
  • 555
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS